TQB2450 injection combined with anlotinib hydrochloride capsule in the treatment of advanced, recurrent or metastatic endometrial cancer: A multicohort, open label, multicenter phase II clinical trial - The TQB2450-II-08 trial-MedSci.cn

TQB2450 injection combined with anlotinib hydrochloride capsule in the treatment of advanced, recurrent or metastatic endometrial cancer: A multicohort, open label, multicenter phase II clinical trial - The TQB2450-II-08 trial

Wu, X; Liang, S; Chen, X; Hou, J; Wang, K; Wang, D; An, R; Zang, A; Li, X; Zhang, B; Qu, P; Duan, W; Yu, G; Wang, D; Yan, D; Wang, J; Yao, D; Wang, S; Zhao, W; Lou, H

ANNALS OF ONCOLOGY, 2022; 33 (7): S802

科室
- - 订阅+
  - 更多科室
工具
服务